Concepts (190)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endosonography | 12 | 2016 | 56 | 1.750 |
Why?
|
| Endoscopes, Gastrointestinal | 12 | 2010 | 12 | 0.870 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 6 | 2016 | 32 | 0.690 |
Why?
|
| Endoscopy, Gastrointestinal | 9 | 2013 | 25 | 0.610 |
Why?
|
| Gallbladder Diseases | 2 | 2010 | 7 | 0.610 |
Why?
|
| Cholestasis | 3 | 2012 | 18 | 0.490 |
Why?
|
| Barrett Esophagus | 1 | 2014 | 3 | 0.480 |
Why?
|
| Precancerous Conditions | 1 | 2014 | 27 | 0.470 |
Why?
|
| Esophageal Neoplasms | 1 | 2014 | 35 | 0.460 |
Why?
|
| Biliary Tract Diseases | 3 | 2012 | 12 | 0.460 |
Why?
|
| Catheter Ablation | 1 | 2014 | 67 | 0.450 |
Why?
|
| Biliary Tract | 2 | 2012 | 7 | 0.440 |
Why?
|
| Lymphangioma, Cystic | 1 | 2012 | 1 | 0.420 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 308 | 0.380 |
Why?
|
| Pancreatic Diseases | 3 | 2009 | 18 | 0.370 |
Why?
|
| Pancreatic Neoplasms | 1 | 2012 | 134 | 0.370 |
Why?
|
| Polyps | 1 | 2010 | 8 | 0.360 |
Why?
|
| Cholecystectomy | 1 | 2010 | 22 | 0.360 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 94 | 0.340 |
Why?
|
| Liver Diseases | 1 | 2009 | 70 | 0.320 |
Why?
|
| Humans | 42 | 2019 | 32005 | 0.300 |
Why?
|
| Biopsy, Fine-Needle | 4 | 2013 | 53 | 0.280 |
Why?
|
| Liver | 1 | 2009 | 484 | 0.260 |
Why?
|
| Intestinal Mucosa | 3 | 2019 | 71 | 0.260 |
Why?
|
| Gastrointestinal Diseases | 5 | 2009 | 43 | 0.260 |
Why?
|
| Liver Failure | 1 | 2005 | 20 | 0.250 |
Why?
|
| Stents | 2 | 2009 | 177 | 0.240 |
Why?
|
| Colonoscopy | 4 | 2019 | 45 | 0.220 |
Why?
|
| Respiratory Mucosa | 1 | 2003 | 12 | 0.220 |
Why?
|
| Mucins | 1 | 2003 | 18 | 0.220 |
Why?
|
| Equipment Design | 11 | 2010 | 171 | 0.210 |
Why?
|
| Epithelial Cells | 1 | 2003 | 141 | 0.200 |
Why?
|
| Sensitivity and Specificity | 5 | 2012 | 582 | 0.200 |
Why?
|
| Catheterization | 3 | 2010 | 58 | 0.190 |
Why?
|
| Device Approval | 2 | 2010 | 6 | 0.180 |
Why?
|
| United States Food and Drug Administration | 2 | 2010 | 45 | 0.180 |
Why?
|
| Endoscopy, Digestive System | 2 | 2009 | 10 | 0.160 |
Why?
|
| Diagnosis, Differential | 3 | 2012 | 517 | 0.160 |
Why?
|
| Male | 11 | 2019 | 19165 | 0.160 |
Why?
|
| Gastrointestinal Neoplasms | 2 | 2008 | 31 | 0.150 |
Why?
|
| Technology Assessment, Biomedical | 4 | 2009 | 11 | 0.140 |
Why?
|
| Digestive System Diseases | 1 | 2016 | 6 | 0.140 |
Why?
|
| Choledocholithiasis | 1 | 2016 | 3 | 0.140 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2016 | 20 | 0.130 |
Why?
|
| Intraoperative Care | 1 | 2016 | 48 | 0.130 |
Why?
|
| Female | 10 | 2016 | 19959 | 0.120 |
Why?
|
| Endoscopy | 2 | 2019 | 58 | 0.120 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2013 | 12 | 0.110 |
Why?
|
| Middle Aged | 7 | 2019 | 11817 | 0.110 |
Why?
|
| Sphincterotomy, Endoscopic | 2 | 2010 | 5 | 0.110 |
Why?
|
| Lymphatic Diseases | 1 | 2012 | 10 | 0.110 |
Why?
|
| Surgical Instruments | 2 | 2009 | 24 | 0.100 |
Why?
|
| Equipment Safety | 5 | 2010 | 20 | 0.100 |
Why?
|
| Lymph Nodes | 1 | 2012 | 107 | 0.100 |
Why?
|
| Video Recording | 2 | 2010 | 59 | 0.100 |
Why?
|
| Adult | 5 | 2016 | 9345 | 0.100 |
Why?
|
| Evidence-Based Medicine | 2 | 2010 | 217 | 0.090 |
Why?
|
| Equipment Failure | 1 | 2010 | 24 | 0.090 |
Why?
|
| Pancreatic Pseudocyst | 1 | 2010 | 5 | 0.090 |
Why?
|
| Pancreatitis, Chronic | 1 | 2010 | 8 | 0.090 |
Why?
|
| Gastrostomy | 1 | 2010 | 17 | 0.090 |
Why?
|
| Reproducibility of Results | 3 | 2008 | 762 | 0.090 |
Why?
|
| Calculi | 1 | 2009 | 2 | 0.090 |
Why?
|
| Gallstones | 1 | 2009 | 11 | 0.090 |
Why?
|
| Microscopy | 1 | 2009 | 26 | 0.090 |
Why?
|
| Cathartics | 1 | 2009 | 5 | 0.080 |
Why?
|
| Hemostasis, Surgical | 1 | 2009 | 13 | 0.080 |
Why?
|
| Disinfection | 1 | 2009 | 5 | 0.080 |
Why?
|
| Microscopy, Confocal | 1 | 2009 | 65 | 0.080 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2009 | 23 | 0.080 |
Why?
|
| Colonography, Computed Tomographic | 1 | 2009 | 10 | 0.080 |
Why?
|
| Bile Duct Neoplasms | 1 | 2009 | 32 | 0.080 |
Why?
|
| Gallbladder Neoplasms | 1 | 2009 | 34 | 0.080 |
Why?
|
| Capsule Endoscopy | 1 | 2008 | 3 | 0.080 |
Why?
|
| Gastric Mucosa | 1 | 2008 | 13 | 0.080 |
Why?
|
| Endoscopes | 1 | 2008 | 4 | 0.080 |
Why?
|
| Preoperative Care | 1 | 2009 | 114 | 0.080 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2008 | 37 | 0.080 |
Why?
|
| Radiography | 1 | 2009 | 376 | 0.080 |
Why?
|
| Image Enhancement | 1 | 2008 | 72 | 0.080 |
Why?
|
| Severity of Illness Index | 2 | 2008 | 881 | 0.070 |
Why?
|
| Intestine, Small | 1 | 2007 | 40 | 0.070 |
Why?
|
| Forecasting | 1 | 2008 | 143 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2009 | 155 | 0.070 |
Why?
|
| Linoleic Acids, Conjugated | 1 | 2007 | 7 | 0.070 |
Why?
|
| Coloring Agents | 1 | 2007 | 29 | 0.070 |
Why?
|
| Ultrasonography, Interventional | 1 | 2007 | 53 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2019 | 3306 | 0.070 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2006 | 24 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2016 | 3509 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 538 | 0.070 |
Why?
|
| Prognosis | 1 | 2010 | 1497 | 0.070 |
Why?
|
| Predictive Value of Tests | 3 | 2016 | 876 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 2265 | 0.060 |
Why?
|
| Controlled Clinical Trials as Topic | 3 | 2010 | 10 | 0.060 |
Why?
|
| Body Composition | 1 | 2007 | 397 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2006 | 215 | 0.060 |
Why?
|
| Disease-Free Survival | 1 | 2005 | 317 | 0.060 |
Why?
|
| Health Status | 1 | 2006 | 399 | 0.060 |
Why?
|
| Uridine Triphosphate | 1 | 2003 | 1 | 0.050 |
Why?
|
| Adenosine Diphosphate | 1 | 2003 | 5 | 0.050 |
Why?
|
| Goblet Cells | 1 | 2003 | 5 | 0.050 |
Why?
|
| Second Messenger Systems | 1 | 2003 | 6 | 0.050 |
Why?
|
| Nitric Oxide Donors | 1 | 2003 | 8 | 0.050 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2003 | 8 | 0.050 |
Why?
|
| United States | 5 | 2010 | 3939 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2003 | 53 | 0.050 |
Why?
|
| Bronchi | 1 | 2003 | 33 | 0.050 |
Why?
|
| Species Specificity | 1 | 2003 | 90 | 0.050 |
Why?
|
| Adenosine | 1 | 2003 | 59 | 0.050 |
Why?
|
| Vasodilator Agents | 1 | 2003 | 62 | 0.050 |
Why?
|
| Transplantation, Heterologous | 1 | 2003 | 122 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2003 | 167 | 0.050 |
Why?
|
| Trachea | 1 | 2003 | 52 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2003 | 111 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2008 | 1426 | 0.050 |
Why?
|
| Mice, Nude | 1 | 2003 | 291 | 0.050 |
Why?
|
| Double-Blind Method | 2 | 2016 | 525 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2003 | 833 | 0.050 |
Why?
|
| Diet, Gluten-Free | 1 | 2019 | 3 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2019 | 12 | 0.040 |
Why?
|
| Neuroendocrine Tumors | 1 | 2019 | 18 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2019 | 83 | 0.040 |
Why?
|
| Diarrhea | 1 | 2019 | 60 | 0.040 |
Why?
|
| Obesity | 1 | 2007 | 1175 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2019 | 122 | 0.040 |
Why?
|
| Collagen | 1 | 2019 | 225 | 0.040 |
Why?
|
| Needles | 2 | 2009 | 31 | 0.040 |
Why?
|
| Enema | 2 | 2009 | 6 | 0.040 |
Why?
|
| Child | 2 | 2016 | 2438 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2019 | 379 | 0.040 |
Why?
|
| Mice | 1 | 2003 | 2484 | 0.030 |
Why?
|
| Hospitalization | 1 | 2019 | 470 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2016 | 2282 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 3990 | 0.030 |
Why?
|
| Cholangiography | 1 | 2016 | 12 | 0.030 |
Why?
|
| Smoking | 1 | 2019 | 497 | 0.030 |
Why?
|
| Animals | 2 | 2010 | 7541 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2008 | 510 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 918 | 0.030 |
Why?
|
| Abdomen | 1 | 2012 | 43 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2016 | 1269 | 0.030 |
Why?
|
| Aged | 2 | 2016 | 10301 | 0.020 |
Why?
|
| Compassionate Use Trials | 1 | 2010 | 3 | 0.020 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2010 | 7 | 0.020 |
Why?
|
| Medical Device Recalls | 1 | 2010 | 2 | 0.020 |
Why?
|
| Off-Label Use | 1 | 2010 | 12 | 0.020 |
Why?
|
| Current Procedural Terminology | 1 | 2010 | 3 | 0.020 |
Why?
|
| Observer Variation | 1 | 2010 | 105 | 0.020 |
Why?
|
| Lasers, Gas | 1 | 2009 | 3 | 0.020 |
Why?
|
| Hemostatics | 1 | 2009 | 11 | 0.020 |
Why?
|
| Pancreas | 1 | 2010 | 103 | 0.020 |
Why?
|
| Syringes | 1 | 2009 | 5 | 0.020 |
Why?
|
| Electrocoagulation | 1 | 2009 | 12 | 0.020 |
Why?
|
| Laser Coagulation | 1 | 2009 | 13 | 0.020 |
Why?
|
| Ligation | 1 | 2009 | 56 | 0.020 |
Why?
|
| Device Removal | 1 | 2009 | 33 | 0.020 |
Why?
|
| Dissection | 1 | 2008 | 17 | 0.020 |
Why?
|
| Miniaturization | 1 | 2008 | 5 | 0.020 |
Why?
|
| Fiber Optic Technology | 1 | 2008 | 15 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2008 | 44 | 0.020 |
Why?
|
| Total Quality Management | 1 | 2008 | 17 | 0.020 |
Why?
|
| Forms and Records Control | 1 | 2008 | 7 | 0.020 |
Why?
|
| Safety Management | 1 | 2008 | 37 | 0.020 |
Why?
|
| Adolescent | 1 | 2016 | 3539 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2008 | 52 | 0.020 |
Why?
|
| Safety | 1 | 2007 | 77 | 0.020 |
Why?
|
| Injections | 1 | 2007 | 64 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2007 | 93 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2008 | 163 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2007 | 99 | 0.020 |
Why?
|
| Rest | 1 | 2007 | 53 | 0.020 |
Why?
|
| Sigmoidoscopy | 1 | 2006 | 3 | 0.020 |
Why?
|
| Barium Sulfate | 1 | 2006 | 7 | 0.020 |
Why?
|
| Occult Blood | 1 | 2006 | 9 | 0.020 |
Why?
|
| ROC Curve | 1 | 2007 | 164 | 0.020 |
Why?
|
| Energy Intake | 1 | 2007 | 128 | 0.020 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2006 | 63 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 276 | 0.020 |
Why?
|
| Hyperthermia, Induced | 1 | 2009 | 243 | 0.020 |
Why?
|
| Contrast Media | 1 | 2006 | 138 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2006 | 297 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2007 | 147 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2006 | 124 | 0.020 |
Why?
|
| Body Weight | 1 | 2007 | 310 | 0.020 |
Why?
|
| Comorbidity | 1 | 2006 | 566 | 0.020 |
Why?
|
| Motor Activity | 1 | 2007 | 325 | 0.020 |
Why?
|
| Mass Screening | 1 | 2006 | 263 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2006 | 411 | 0.010 |
Why?
|
| Neoplasms | 1 | 2007 | 726 | 0.010 |
Why?
|